SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001341004-13-000331
Filing Date
2013-03-20
Accepted
2013-03-20 17:27:10
Documents
2
Group Members
ODYSSEUS ACQUISITION CORP.VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 SC TO-C FOR VALEANT PHARMACEUTICALS, INC. sc_to-c.htm SC TO-C 25171
2 EXHIBIT (A)(5)(A) PRESS RELEASE ISSUED ON MARCH 20, 2013 exa5a.htm EX-99 11663
  Complete submission text file 0001341004-13-000331.txt   38730
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806
Business Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806 562-628-1007
Obagi Medical Products, Inc. (Subject) CIK: 0001375247 (see all company filings)

IRS No.: 954658730 | State of Incorp.: DE | Fiscal Year End: 0710
Type: SC TO-C | Act: 34 | File No.: 005-82589 | Film No.: 13705829
SIC: 2834 Pharmaceutical Preparations